Synergy CHC Corp. (NASDAQ: SNYR) Appoints Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America

Synergy CHC Corp. (NASDAQ: SNYR), a prominent consumer health and wellness company, has appointed Pedro Colmenares as the new Director of Sales & Marketing for Mexico and Latin America, a crucial role aimed at steering the company’s commercial strategy and market expansion within the region. This appointment comes during a strategic period for Synergy, which has recently established a wholly owned subsidiary in Mexico, marking its entry into the Latin American market with shipments of its supplement products to Costco Mexico.

Jack Ross, CEO of Synergy CHC, expressed enthusiasm over Colmenares’ onboarding, highlighting his extensive regional experience and proven track record in building successful commercial platforms. Colmenares brings over 18 years of expertise across pharmaceutical, nutraceutical, OTC, and consumer health sectors, having held leadership positions at major companies including Procter & Gamble and Victus/Megalabs. His background demonstrates a solid capability in transforming underdeveloped markets into profitable ventures through strategic distribution partnerships and effective go-to-market strategies.

In his new role, Colmenares will focus on not only expanding the company’s supplement and functional beverage portfolios but also creating a sustainable commercial foundation for long-term growth across the region. He is particularly excited about the potential of Synergy’s flagship FOCUSfactor brand and is committed to building strong partnerships to foster growth in these emerging markets.

Synergy CHC Corp. is known for developing innovative health and wellness products under its leading brands, such as FOCUSfactor, a clinically studied brain health supplement, and Flat Tummy, focusing on women’s wellness. With an established presence in various retail channels, Synergy aims to accelerate its growth trajectory both domestically and internationally.

**Market Advice on Synergy CHC Corp. (NASDAQ: SNYR)**

The recent appointment of Pedro Colmenares as Director of Sales & Marketing for Mexico & Latin America at Synergy CHC Corp. represents a strategic move that could significantly enhance the company's market presence in the high-potential Latin American region. With Colmenares’ extensive experience in building commercial platforms for consumer health products, his leadership is likely to be pivotal for Synergy as it executes its international growth strategy.

Synergy has already initiated its expansion into Mexico, evidenced by its entry into Costco Mexico and the establishment of a subsidiary. This move not only diversifies its revenue streams but also positions Synergy to leverage the growing demand for health and wellness products in Latin America, a market characterized by increasing consumer awareness and spending power.

Investors should consider that Synergy's flagship products, such as FOCUSfactor, are well-established in North America and have potential for growth in new international markets. Colmenares’ proven ability to launch and expand operations across diverse regions suggests that he might successfully replicate similar successes for Synergy’s product lines in Latin America. His focus on localized brand development and partnerships aligns well with the company’s strategy to build sustainable growth in these emerging markets.

Additionally, with the health and wellness sector experiencing a robust trend toward supplements and functional foods, Synergy is positioned well to capitalize on these opportunities. The current timing, coupled with Colmenares’ insights into local market dynamics, provides a promising outlook for shareholders.

Given these favorable developments, investors might consider a bullish stance on SNYR, especially as we approach the end of 2025, when initial results from Latin America's market performance may start to materialize. Monitoring the company's quarterly performance and updates on their international strategy execution will be crucial for making informed investment decisions.